Discover the obesity therapeutics market's expansion to US$20.84 billion by 2033 with 20.6% CAGR. Key insights on GLP-1 class dominance, generics/biosimilars for accessibility, and M&A activity fueled by players like AstraZeneca targeting US$6 billion revenue by 2030. https://finance.yahoo.com/news/competitive-landscape-obesity-therapeutics-market-141800112.html